Government 'delays could threaten' new £450m facility in Liverpool
Government delays could threaten a £450m investment in a huge new vaccine facility in Liverpool, according to reports. Last ...
Reeves to go ‘further and faster’ for growth after recent turmoil
A barrage of grim UK economic data this month has given chancellor Rachel Reeves “permission” to pursue a more aggressive growth agenda, according to senior government officials, trampling on Labour ...
The UK7d
City prepares for fifth annual tech industry celebration aiming to generate investment
Tech Climbers returns to the Liverpool City Region next month for a fifth year, celebrating half a decade of profiling the ...
Dithering Labour government blamed for delays in £450 million vaccine plant investment
AstraZeneca's bold vision for a cutting-edge vaccine facility in Speke is caught in a web of delays, leaving the biotech ...
Seeking Alpha23d
AstraZeneca: Uncertainty Ahead, Neutral Rating Confirmed.
AstraZeneca still trades at a premium valuation, but several factors limit its upside potential in the next visible period. There are three negative takeaways from China. IRA could also ...
Business Standard27d
Focus on next-gen therapeutics, AstraZeneca to restructure biopharma unit
UK-based pharmaceutical giant AstraZeneca has announced plans to restructure its biopharma unit to concentrate on next-generation therapeutics. “In the Biopharmaceutical Business Unit, we are now ...
The Daily Telegraph29d
AstraZeneca sued for discrimination after ‘refusing’ to let eczema sufferer work from home
IT worker can continue legal battle against pharmaceutical giant after judge rules that impact of skin condition makes him a disabled person An IT worker has won a legal battle to sue AstraZeneca ...